Individualized conditional survival nomograms for stage I-III early onset colorectal cancer patients

被引:3
|
作者
Chen, Min [1 ,2 ]
Chen, Ting [1 ]
机构
[1] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu, Peoples R China
[2] Nanjing Univ Chinese Med, Changshu Hosp, Dept Gen Surg, Changshu 215500, Peoples R China
关键词
early onset colorectal cancer; conditional survival; nomogram; overall survival; cancer-specific survival;
D O I
10.1093/jjco/hyac169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Conditional survival accounts for the time already survived after surgery and provides additional survival information. The aim was to assess conditional survival in stages I-III early onset colorectal cancer patients and to create nomograms predicting the conditional overall survival and cancer-specific survival after surgery. Methods A total of 7058 patients who underwent surgical resection of early onset colorectal cancer were identified from surveillance, epidemiology and end results database. The formula used for conditional survival calculation was conditional survival((x|y)) = S(x + y)/S-(x), where S-(x) represents the survival at x years. Conditional survival nomograms were then developed to predict the 5-year conditional overall survival and cancer-specific survival. Results The 5-year overall survival and cancer-specific survival after surgery increases gradually with additional survival time. Race, tumour site, grade, histology, T stage, N stage, lymph node ratio, preoperative carcinoma embryonic antigen level and perineural invasion status were independent predictors of cancer-specific survival, while age and sex were another two independent risk factors for overall survival. The nomograms based on these factors were successfully developed to predict 5-year overall survival and cancer-specific survival given 1-4 years already survived. Conclusion The probability of achieving postoperative 5-year overall survival and cancer-specific survival for early onset colorectal cancer increases gradually with additional time survived. The developed nomograms are fairly valuable and informative in facilitating clinical treatment and follow-up schemes. No previous studies have attempted to analyse the conditional survival for early onset colorectal cancer patients. We successfully developed nomograms to predict conditional survival with considerable prognostic accuracy for these patients.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [41] Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study
    Hopkins, Jessica J.
    Reif, Rebecca
    Bigam, David
    Baracos, Vickie E.
    Eurich, Dean T.
    Sawyer, Michael M.
    WORLD JOURNAL OF SURGERY, 2019, 43 (10) : 2518 - 2526
  • [42] Surgical treatment experience for patients with stage I-III esophageal cancer
    Kolesnik, O. P.
    Kolesnyk, I. P.
    Kechedzhyiev, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (03) : 448 - 453
  • [43] Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis
    Aiken, Taylor
    Hu, Chung-Yuan
    Uppal, Abhineet
    Francescatti, Amanda B.
    Fournier, Keith F.
    Chang, George J.
    Zafar, Syed Nabeel
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 127 (04) : 678 - 687
  • [44] Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium
    Damerell, Victoria
    Brezina, Stefanie
    Ose, Jennifer
    Geijsen, Anne Jmr
    Ulvik, Arve
    Van Roekel, Eline H.
    Holowatyj, Andreana N.
    Kok, Dieuwertje E.
    van Duijnhoven, Franzel J. B.
    Li, Christopher I.
    Habermann, Nina
    Ulrich, Alexis B.
    Kampman, Ellen
    Weijenberg, Matty P.
    Gsur, Andrea
    Ueland, Per M.
    Schneider, Martin
    Ulrich, Cornelia M.
    Gigic, Biljana
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Factors associated with survival in older patients with stage I-III colorectal carcinoma who were not managed curatively in the Netherlands
    Vondeling, Ariel M.
    Hazen, Josje C. E. P.
    van Huis-Tanja, Lieke H.
    Schiphorst, Anandi H. W.
    van der Bol, Jessica
    Dekker, Jan Willem
    Hamaker, Marije E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (05) : 667 - 672
  • [46] Novel body component score predicts long-term survival in patients with stage I-III colorectal cancer following radical resection
    Aida, Takashi
    Kamada, Teppei
    Hata, Taigo
    Takahashi, Junji
    Ito, Eisaku
    Furukawa, Kenei
    Yoshida, Masashi
    Ohdaira, Hironori
    Ikegami, Toru
    Suzuki, Yutaka
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024,
  • [47] Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery
    Kamada, Teppei
    Haruki, Koichiro
    Nakashima, Keigo
    Takahashi, Junji
    Nakaseko, Yuichi
    Suzuki, Norihiko
    Ohdaira, Hironori
    Eto, Ken
    Ikegami, Toru
    Suzuki, Yutaka
    SURGERY TODAY, 2023, 53 (9) : 1064 - 1072
  • [48] Individualized conditional survival nomograms for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and radical surgery
    Zheng, Zhifang
    Wang, Xiaojie
    Liu, Zhun
    Lu, Xingrong
    Huang, Ying
    Chi, Pan
    EJSO, 2021, 47 (12): : 3175 - 3181
  • [49] Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection
    Xu, Rui
    You, Junhao
    Li, Fang
    Yan, Bing
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [50] Comparison of survival of stage I-III colon cancer by travel distance and hospital volume
    Turner, M. C.
    Jawitz, O.
    Adam, M. A.
    Srinivasan, E.
    Niedzwiecki, D.
    Migaly, J.
    Fisher, D. A.
    Mantyh, C. R.
    TECHNIQUES IN COLOPROCTOLOGY, 2020, 24 (07) : 703 - 710